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Characterization of Cleavage Events in the Multifunctional Cilium
Adhesin Mhp684 (P146) Reveals a Mechanism by Which Mycoplasma
hyopneumoniae Regulates Surface Topography
Daniel R. Bogema,a,b Ania T. Deutscher,a,b Lauren K. Woolley,a,b Lisa M. Seymour,b,c Benjamin B. A. Raymond,d Jessica L. Tacchi,d
Matthew P. Padula,d Nicholas E. Dixon,e F. Chris Minion,f Cheryl Jenkins,a Mark J. Walker,b,c and Steven P. Djordjevica,d
NSW Department of Primary Industries, Elizabeth Macarthur Agricultural Institute, Camden, NSW, Australiaa; School of Biological Sciences, University of Wollongong,
Wollongong, NSW, Australiab; School of Chemistry and Molecular Biosciences and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane,
QLD, Australiac; The ithree Institute, University of Technology, Sydney, NSW, Australiad; School of Chemistry, University of Wollongong, Wollongong, NSW, Australiae; and
Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, Iowa, USAf
ABSTRACT Mycoplasma hyopneumoniae causes enormous economic losses to swine production worldwide by colonizing the cili-
ated epithelium in the porcine respiratory tract, resulting in widespread damage to the mucociliary escalator, prolonged inflam-
mation, reduced weight gain, and secondary infections. ProteinMhp684 (P146) comprises 1,317 amino acids, and while the
N-terminal 400 residues display significant sequence identity to the archetype cilium adhesin P97, the remainder of the molecule
is novel and displays unusual motifs. Proteome analysis shows that P146 preprotein is endogenously cleaved into three major
fragments identified here as P50P146, P40P146, and P85P146 that reside on the cell surface. Liquid chromatography with tandem
mass spectrometry (LC-MS/MS) identified a semitryptic peptide that delineated a major cleavage site in Mhp684. Cleavage oc-
curred at the phenylalanine residue within sequence 672ATEF2QQ677, consistent with a cleavage motif resembling S/T-X-F2X-
D/E recently identified inMhp683 and other P97/P102 family members. Biotinylated surface proteins recovered by avidin chro-
matography and separated by two-dimensional gel electrophoresis (2-D GE) showed that more-extensive endoproteolytic
cleavage of P146 occurs. Recombinant fragments F1P146-F3P146 that mimic P50P146, P40P146, and P85P146 were constructed and
shown to bind porcine epithelial cilia and biotinylated heparin with physiologically relevant affinity. Recombinant versions of
F3P146 generated fromM. hyopneumoniae strain J and 232 sequences strongly bind porcine plasminogen, and the removal of
their respective C-terminal lysine and arginine residues significantly reduces this interaction. These data reveal that P146 is an
extensively processed, multifunctional adhesin ofM. hyopneumoniae. Extensive cleavage coupled with variable cleavage effi-
ciency provides a mechanism by whichM. hyopneumoniae regulates protein topography.
IMPORTANCE Vaccines used to controlMycoplasma hyopneumoniae infection provide only partial protection. Proteins of the
P97/P102 families are highly expressed, functionally redundant molecules that are substrates of endoproteases that generate
multifunctional adhesin fragments on the cell surface. We show that P146 displays a chimeric structure consisting of an N termi-
nus, which shares sequence identity with P97, and novel central and C-terminal regions. P146 is endoproteolytically processed at
multiple sites, generating at least nine fragments on the surface ofM. hyopneumoniae. Dominant cleavage events occurred at
S/T-X-F2X-D/E-like sites generating P50P146, P40P146, and P85P146. Recombinant proteins designed to mimic the major cleavage
fragments bind porcine cilia, heparin, and plasminogen. P146 undergoes endoproteolytic processing events at multiple sites and
with differential processing efficiency, generating combinatorial diversity on the surface ofM. hyopneumoniae.
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Genome-reduced pathogens typically display host-restrictedbehavior but retain the capacity to deploy complex mecha-
nisms to effectively colonize mucosal sites critical for their dissem-
ination to naive hosts. Mycoplasma species have evolved strategies
to vary their surface topography to avoid detection and eradica-
tion by the host immune response (1). Mycoplasmas are the
smallest self-replicating life forms with most genomes ranging in
size from 500 to 1,300 kb. Gene families encoding proteins dis-
played on the surface with reiterated sequences in their promoter
or coding regions are highly mutable due to slip strand mispairing
and have been reported in a number ofMycoplasma species (2–4).
Mutations in these reiterated regions generate phase (on/off) and
size variants that contribute to surface diversity and immune eva-
sion. Mycoplasma hyopneumoniae is unusual in this regard with
analysis of four complete genome sequences failing to find evi-
dence of reiterated sequences capable of inducing variable expres-
sion of most dominant surface proteins (5–7). Despite this, M.
hyopneumoniae causes porcine enzootic pneumonia, a chronic
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geographically widespread respiratory disease that inflicts severe
economic losses to pig production (8, 9).
Within the confines of commercial swine-rearing facilities, M.
hyopneumoniae enters naive animals via the inhalation of muco-
respiratory droplets expelled during bouts of coughing from M.
hyopneumoniae-infected swine (10). Upon inhalation, M. hyo-
pneumoniae must overcome the mucociliary escalator and tra-
verse layers of heavily glycosylated mucins produced as decoys for
bacterial adhesins that exploit surface glycoconjugates and extra-
cellular matrix components during colonization. M. hyopneu-
moniae is highly adept at colonizing ciliated respiratory epithelia
(11, 12) where it initially causes ciliostasis but eventually destroys
cilia and induces epithelial cell death. Heparin effectively blocks
the binding of M. hyopneumoniae to porcine cilial preparations
(13), indicating that M. hyopneumoniae is reliant on the presenta-
tion of heparin-binding proteins on its cell surface. Proteoglycans
with highly sulfated glycosaminoglycan (GAG) side chains are
prominently displayed on the surface of ciliated epithelium lining
the porcine respiratory tract (14). Enzootic pneumonia is a
chronic disease, and adaptive immune responses must be evaded
for M. hyopneumoniae to survive and proliferate within host tis-
sues. Consequently, the ability to adhere tightly to respiratory cilia
is a key strategy employed by pathogens to overcome the muco-
ciliary escalator (11, 13, 15, 16).
Functional redundancy within key surface protein families is
identified in multiple pathogens and may be a strategy to avoid
immune responses and regulate both adhesion to host tissues and
cellular invasion (17, 18). In M. hyopneumoniae, multifunctional
adhesins belonging to the P97/P102 families include Mhp182
(P102), Mhp183 (P97), Mhp493 (P159), Mhp494 (P216),
Mhp683 (P135), Mhp271, Mhp107, and Mhp108 (P116). These
adhesins are prominently expressed during broth culture (19–29),
and their expression in vivo is indicated by reverse transcription-
PCR (RT-PCR) of M. hyopneumoniae mRNA recovered from the
bronchoalveolar lavage (BAL) fluid of experimentally infected
swine (30). P97/P102 paralog family members on the cell surface
of M. hyopneumoniae are targets of endoproteolytic processing
events that generate a substantial combinatorial repertoire of
cleavage fragments. Fragments of P97, P216, P135, Mhp271,
Mhp107, and Mhp108 have been shown to bind porcine cilia (21–
26), underscoring their important role in colonizing the respira-
tory tracts of swine. Additionally, fragments derived from P97,
P159, P216, P135, Mhp271, and Mhp107 are potent adhesins of
heparin (19, 21, 22, 24, 26, 31). Interactions between microbial
virulence factors and host GAGs underpin a plethora of patho-
genic mechanisms including adhesion, invasion, and tissue tro-
pism (18). These findings suggest that endoproteolytic fragments
derived from P97/P102 paralog family members profoundly in-
fluence how M. hyopneumoniae interacts with its host.
Binding of plasminogen and fibronectin to the surface of M.
hyopneumoniae is dose dependent and saturable (24–26), indicat-
ing that these two host proteins are also important targets during
the infection process. Surface proteins P102 (27), P102 paralog
Mhp108 (P116) (25), and P97 paralog Mhp107 (26) are strong
plasminogen- and fibronectin-binding proteins, and the P97
paralog Mhp271 also binds fibronectin (24). Plasminogen is freely
available at ciliated epithelial sites and in BAL fluid samples recov-
ered from healthy and M. hyopneumoniae-infected swine. How-
ever, plasmin activity in BAL fluid samples increase significantly
after challenge with M. hyopneumoniae (27). These observations
indicate that M. hyopneumoniae engages the plasminogen activa-
tion system during colonization of the respiratory tract. More-
over, plasminogen exposed to recombinant P102 is more readily
activated to plasmin in the presence of tissue-specific plasminogen
activator (tPA). These data suggest that plasminogen-binding
members of the P97/P102 paralog families can influence the ter-
tiary structure of plasminogen, making it more susceptible to ac-
tivation by plasminogen activators (27). Collectively, our studies
show that P97/P102 paralog family members display discrete
functional domains with multifunctional attributes and are key
molecules in the pathogenic arsenal of M. hyopneumoniae.
Endoproteolytic processing is a well-known mechanism used
by bacterial pathogens to convert immature preproteins into ma-
ture functioning virulence molecules; however, in the M. hyo-
pneumoniaeP97/P102 adhesin families, posttranslational cleavage
is extensive and unorthodox. Most of the P97/P102 family mem-
bers previously examined undergo at least one cleavage event and
in some cases two or more cleavage events (19–22, 28, 29). The
archetype cilium adhesin P97 itself undergoes extensive process-
ing, creating many novel endoproteolytic fragments, but many of
these fragments have not been experimentally characterized (20).
Cleavage fragments reside on the surfaces of M. hyopneumoniae
cells despite the lack of putative transmembrane domains (19–27,
30). Recently, the identification of an endoproteolytic cleavage
motif with sequence S/T-X-F2X-D/E has facilitated the predic-
tion of cleavage sites among members of the P97/P102 families
(22); however, the biological rationale for cleavage and the pro-
tease(s) responsible are yet to be determined.
The P146 adhesin-like-protein (Mhp684) is a paralog of the
P97 cilium adhesin, and its corresponding gene is situated within
a two-gene operon with the cilium- and heparin-binding protein
P135 (Mhp683) (6). The gene itself is transcribed in vivo (30) and
has garnered interest as a target for genotyping M. hyopneu-
moniae, due to its extensive variability in strains (32). A polyserine
repeat (P146R3) is observed to vary considerably among the se-
quenced strains ofM. hyopneumoniae (5–7). In this study, we have
characterized binding functions of P146 and determined how it is
endoproteolytically processed.
RESULTS
P146 is extensively processed on the surface of M. hyopneu-
moniae. In pathogenic strain 232 of M. hyopneumoniae, the p97
(mhp183) paralog p146 (mhp684) encodes a 148.2-kDa protein
with a theoretical pI of 8.79. Homologs of p146 have been identi-
fied in the genome sequences of M. hyopneumoniae strains J
(mhj_0663), 7448 (mhp7448_0663), and 168 (mhp168_676) (5–
7). Additionally, p146 homologs have been identified and se-
quenced in strains F7.2C and BQ14 and partially sequenced in
strains PMS and 7422 (32, 33). The six full-length p146 gene se-
quences share85% identity. The TMHMM algorithm identified
a transmembrane domain (P 0.999) spanning residues 7 to 29;
however, SignalP 4.0 did not conclusively identify the presence of
a putative signal peptide (D score of 0.44; signal peptide cutoff of
D score of0.45).
Several members of the P97 and P102 families undergo exten-
sive posttranslational cleavage (19–22, 24, 25, 28, 29). Expression
of P146 by M. hyopneumoniae strain J in broth culture was estab-
lished by using liquid chromatography with tandem mass spec-
trometry (LC-MS/MS) to identify tryptic peptides derived from
proteins separated by SDS-PAGE (Fig. 1). Consistent with previ-
Bogema et al.
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ously characterized P97/P102 family members and proteomic
studies of M. hyopneumoniae (28, 29), we were unable to identify
any peptides unique to P146 near its predicted mass of 148.2 kDa.
Tryptic peptides spanning P146 mapped to three endoproteolytic
fragments, indicating that P146 is cleaved twice. A protein that
migrated with mass between 40 and 53 kDa (slice 8) mapped to the
N-terminal region of P146 (Fig. 1A) (P50P146). Peptides matching
the central region of the P146 sequence were identified in slices 8
(40 to 53 kDa) and 9 (39 to 42 kDa) (Fig. 1B) (P40P146), and
peptides matching the C-terminal region were identified in slice 6
(70 to 90 kDa) (Fig. 1C) (P85P146). Recently, we proposed a cleav-
age motif with sequence S/T-X-F2X-D/E that can be used to
predict cleavage sites in the P97 and P102 paralog families (22).
Two sequences that closely resemble this motif were identified
within the cleavage regions defined by mass spectrometry. The
first of these sequences, TYFAE, resides between amino acids 315
and 366 that separate matched peptides defining P50P146 and
P40P146. However, we have been unable to experimentally confirm
cleavage at the phenylalanine residue in TYFAE. The second mo-
tif, with sequence TEFQQ, resides between residues 630 and 675
FIG 1 Mass spectrometry analysis of P146. M. hyopneumoniae strain J proteins were examined using the following two methods. In method 1, lysates were
subjected to 1-D SDS-PAGE, the gels were sectioned into pieces representing 14 molecular mass ranges, and the proteins in each gel slice were examined using
LC-MS/MS. In method 2, surface proteins were labeled by surface biotinylation and enriched by affinity chromatography of the cell lysate. Purified biotinylated
proteins were separated by either 1-D SDS-PAGE or 2-D GE and identified by LC-MS/MS. Peptides identified by LC-MS/MS are shown in bold type and
underlined. The numbers above or below the sequence refer to amino acid positions. (A to C) Peptides unique to three regions of the P146 sequence were
identified in both experiments. Terminal sequences matching anM. hyopneumoniae cleavage motif defined previously are underlined but not bold. (A) Fragment
P50P146 and peptides unique to the N-terminal region of P146. (B) Fragment P40P146 and peptides unique to the central region of P146. (C) Fragment P85P146
and peptides unique to the C-terminal region of P146. The N terminus of P85P146 was identified from a semitryptic peptide. (D to F) Additional proteins were
identified by method 2 at masses significantly lower than those identified by method 1. Terminal sequences matching or almost matching an M. hyopneumoniae
cleavage motif defined previously (22) are underlined but not bold. (D) Peptides unique to P50P146 were identified in a 1-D SDS-polyacrylamide gel slice
containing proteins migrating at ~25 kDa. (E) Peptides unique to one-half of P50P146 identified in a 2-D GE protein spot migrating at 25 kDa and pI of ~5.5. (F)
Peptides unique to P85P146 identified in 2-D GE protein spots migrating at 50 kDa and pI of ~5.0.
The P146 Adhesin of M. hyopneumoniae
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that separate matched peptides that define P40P146 and P85P146.
Analysis of spectra derived from P85P146 revealed a semitryptic
peptide 676QQQDANSTNSSPTSPSPSPTSPSPASPSSSP-
SPTSPK712 that defines the N terminus of P85P146 (see Fig. S1 in
the supplemental material) and confirms the TEF2QQ cleavage
site.
To determine whether fragments of P146 reside on the surface
of the bacterium, we biotinylated intact M. hyopneumoniae cells
and enriched biotin-conjugated proteins from whole-cell extracts
using a monomeric avidin column. Biotinylated surface proteins
were then separated using both 1- and 2-D GE. Peptides unique to
P50P146, P40P146, and P85P146 were identified from 2-D GE at mo-
lecular masses similar to those from previous 1-D SDS-PAGE with
LC-MS/MS experiments (Fig. 1A to C). However, peptides unique
to P146 fragments were also identified at masses significantly
lower than those identified previously. Tryptic peptides mapping
to P50P146 were identified from proteins with masses of ~25 kDa
(Fig. 1D), indicating that a second, less efficient cleavage event
may occur to separate the P50P146 fragment into two halves. Con-
firming this, peptides unique to the second half of P50P146 were
identified from 2-D GE of biotinylated surface proteins at
~25 kDa (Fig. 1E). A peptide sequence, TKSFQT, similar to but
not matching the S/T-X-F2X-D/E cleavage motif, is found
within the P50P146 fragment, indicating a possible cleavage site.
Peptides unique to the P85P146 fragment were also identified from
2-D GE of biotinylated surface proteins in spots at ~50 kDa
(Fig. 1F), which indicates further cleavage of these fragments.
While surface exposure of P146 endoproteolytic fragments was
observed in biotinylation experiments, we also performed whole-
cell digestion experiments with trypsin. Antisera generated against
recombinant polyhistidine-tagged proteins F1P146, F2bP146, and
F3P146, which recognize P50P146, P40P146, and P85P146, respectively
(Fig. 2), were used to probe blots containing lysates of M. hyo-
pneumoniae strain J cells exposed to different concentrations of
trypsin for 15 min. The blots show that all P146 fragments are
degraded by trypsin, confirming their surface location (see
Fig. S2A in the supplemental material). In all immunoblots, tryp-
sin digestion products are observed in concentrations as low as
0.5 g ml1, and major cleavage products are almost completely
digested at a concentration of 50g ml1. Immunoblots contain-
ing identical lysates probed with antisera raised against the ribo-
somal protein L7/L12 showed that this protein was still detected at
a trypsin concentration of 300 g ml1. Consistent with previous
experiments (19, 21, 22, 25–27), these data indicate that the cell
membrane remained intact. We also performed mass spectrome-
try on peptides released from the surface of M. hyopneumoniae
after trypsin digestion. Multiple peptides unique to all major
cleavage fragments of P146 were identified by LC-MS/MS (see
Fig. S2B in the supplemental material). Live/dead staining and
flow cytometry of M. hyopneumoniae cells confirmed the absence
of excessive cell lysis during trypsin and surface biotinylation ex-
periments (data not shown).
Antibodies from vaccinated, challenged, and convalescent
pigs recognize P146. To determine whether P146 sequences were
recognized by the porcine humoral immune response, sera from
pigs recovering from porcine enzootic pneumonia (convalescent-
phase sera) were used to probe immunoblots of P146 recombi-
nant proteins F1P146, F2P146, and F3P146. The results were com-
pared with results for serum from a pig from a healthy herd (high-
health-status sera) (Fig. 2D). Immunoblots probed with high-
health-status sera (negative control) showed a strong reaction to
F2P146 and weak reactions to F1P146 and F3P146. Immunoblots
probed with sera from two separate convalescent pigs both
showed increased reactions to all three recombinant proteins
compared to the high-health-status sera. In addition to convales-
cent porcine sera, we also examined serum from a single pig vac-
cinated with the commercial bacterin vaccine Suvaxyn and serum
from the same pig after subsequent challenge with a pathogenic
strain of M. hyopneumoniae (Fig. 2E). Immunoblots probed with
sera collected prior to vaccination again showed a strong reaction
to F2P146 but no significant reactions to F1P146 and F3P146. All three
recombinant proteins showed strong reactions when probed with
sera collected after treatment with Suvaxyn and 6 weeks after chal-
lenge with virulent M. hyopneumoniae strain Hillcrest.
P146 is processed variably in M. hyopneumoniae field iso-
lates. To determine whether the cleavage observed in P146 was
consistent across multiple M. hyopneumoniae strains, cell lysates
of laboratory strains and field isolates from varied geographical
locations were analyzed by immunoblotting with anti-F1P146,
anti-F2bP146, and anti-F3P146 sera. Processing of the P85P146,
P50P146, and P40P146 fragments varied among strains (Fig. 3A). In
strain J and field isolates 2-22421 and 95MP1509, strong bands at
40 kDa and 50 kDa were dominant when the blots were probed
with anti-F1P146 and anti-F2bP146 sera, respectively. However, in
strain 232 and field isolates OMZ407, C1735/2, and 00MP1301,
dominant bands were also observed at ~80 and ~125 kDa with
these antisera, indicating that cleavage of P146 may be less efficient
in these strains. An ~80-kDa band that appears in immunoblots
with anti-F1P146 and anti-F2bP146 sera suggests inefficient cleavage
between P50P146 and P40P146, whereas a ~125-kDa band that ap-
pears in immunoblots with anti-F2bP146 and anti-F3P146 sera sug-
gests inefficient cleavage between P40P146 and P85P146. To confirm
this, we performed SDS-PAGE on a cell lysate of M. hyopneu-
moniae strain 232, sectioned the gel with molecular mass range
from 75 to 125 kDa into 6 slices, digested them with trypsin, and
examined the tryptic peptides eluted from each slice using LC-
MS/MS (Fig. 3B). In gel slice 1 (~110 to 125 kDa), peptides unique
to both P40P146 and P85P146 were identified, indicating that an
uncleaved fragment made of P40P146 and P85P146 was present
(Fig. 3C). In gel slices 5 and 6 (~75 to 85 kDa), peptides unique to
P50P146, P40P146, and P85P146 were identified, indicating that an
uncleaved fragment made of P50P146 and P40P146 was present mi-
grating at a molecular mass similar to that of fragment P85P146
(Fig. 3D). In gel slice 4 (~85 to 90 kDa), only peptides unique to
fragment P85P146 were detected. Analysis of M. hyopneumoniae
genome sequences reveals that both the TEFQQ and putative TY-
FAE motifs are present and unchanged in both strains J and 232
(data not shown).
Molecular analysis of P146. P146 contains many striking se-
quence features, including three variable repeat regions, a KEKE
repeat motif, and in strain J, a C terminus with the sequence SSS-
SAPAAAAAKAAK (Fig. 4A). Three repeat regions identified pre-
viously include a proline-glutamine repeat (P146R1) spanning
residues 415 to 444 of the strain 232 sequence, a proline-serine
repeat (P146R2) spanning residues 696 to 722, and a serine repeat
(P146R3) spanning residues 1065 to 1085 (33). All three regions
vary in length in strains (33). The serine repeat varies from 44
consecutive residues in strain 7448, 19 in strain J, and 21 residues
in strain 232 (6, 7).
P146 shares significant sequence identity with P97 family
Bogema et al.
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members of the M. hyopneumoniae genome, but this is essentially
restricted to a region spanning ~400 amino acids from the N ter-
minus. The remainder of the P146 protein is largely unique (6).
Outside of the M. hyopneumoniae genome, BLASTP analysis de-
termines that P146 shares the most similarity with hypothetical
proteins ofMycoplasma conjunctivae: MCJ_004230, MCJ_004150,
MCJ_005100, MCJ_003150, and the LppS adhesin; this is unsur-
prising considering previously reported similarity between ad-
hesins of these Mycoplasma species (34). Analysis of P146 with
coiled-coil prediction algorithms reveals two putative coiled-coil
regions spanning residues 939 to 975 (coil 1) and 1210 to 1245
(coil 2) of the strain 232 sequence. The Paircoil2 (35) (coil 1 P
score 0.0078, coil 2 P score 0.0155; coiled-coil predicted at a
P score of 0.025) and COILS algorithms (36) (coil 1 P score 
0.802, coil 2 P score 1.000) both indicated that coil 1 and coil 2
regions form coiled-coil structures. The coil 2 region corresponds
to a KEKE motif, and interestingly, a putative coiled-coil linked to
a KEKE motif has been observed previously in the P146 operon
partner Mhp683 (22).
Previously we have shown that dominant cleavage sites in P97
and P102 paralogs were located within regions of predicted pro-
tein disorder (22). Five regions of significant structural disorder
were predicted in P146 using the VSL1 algorithm (37) spanning
residues 324 to 508, 589 to 742, 917 to 1016, 1045 to 1098, and
1224 to 1317 (Fig. 4B). Cleavage motifs TYFAE (P50P146/P40P146)
and TEFQQ (P40P146/P85P146) reside within two predicted disor-
FIG2 Cloning of p146 and immunoblot analysis of its cleavage fragments. (A) p146 (3954 bp encoding 1317 residues) was cloned fromM. hyopneumoniae strain
232 homolog mhp684 in three fragments (F1P146/232 to F3P146/232) closely matching native cleavage as observed by mass spectrometry. A hydrophobic trans-
membrane domain predicted by TMHMM (53 residues) was removed from the N terminus of F1P146/232. All in-frame TGA codons were mutated to TGG using
overlap extension PCR. (B) Coomassie blue-stained SDS-PAGE of the three P146 recombinant proteins. The predicted mass (in kilodaltons) is shown above each
gel lane. Recombinant protein F2P146/232 runs at a higher molecular mass than predicted. (C) Immunoblots of recombinant proteins (F1P146/232 to F3P146/232) and
whole-cell lysates from M. hyopneumoniae strains 232 and J, probed with anti-F1P146 (F1P146) and anti-F3P146 (F3P146) sera. Sera labeled F1P146 and F3P146
were extracted from New Zealand White rabbits challenged with recombinants F1P146/232 and F3P146/232; anti-F2bP146 (F2bP146) serum was generated in the
same manner from a recombinant protein representing residues 586 to 690 of P146. Minor bands present in recombinant protein lanes (F1P146/232 to F3P146/232)
may be either products of recombinant protein degradation or truncated proteins resulting from mRNA instability. (D) Immunoblots of recombinant proteins
(F1P146/232 to F3P146/232) probed with porcine serum sourced from a high-health-status herd (blot 1) and sera from convalescent pigs (blots 2 and 3). (E)
Immunoblots of recombinant proteins (F1P146/232 to F3P146/232) probed with sera obtained from a single pig prior to treatment (blot 1), after vaccination with the
commercial bacterin vaccine Suvaxyn (blot 2), or 6 weeks after challenge with M. hyopneumoniae strain Hillcrest (blot 3).
The P146 Adhesin of M. hyopneumoniae
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dered regions spanning amino acids 324 to 508 and 589 to 742.
Interestingly, most of P40P146 is predicted to be disordered, and
this fragment is clearly the most unstable compared to P50P146 and
P85P146. This prediction suggests that P40P146 displays greater ac-
cessibility to endoproteolytic cleavage.
P146 fragments bind heparin.Members of the P97/P102 fam-
ilies have a propensity to bind sulfated GAGs (19, 21, 22, 24, 26,
31). Recombinant fragments F1P146/232 and F3P146/232 bound hep-
arin in a dose-dependent and saturable manner with physiologi-
cally relevant affinity constants, as assessed in microtiter plate-
based enzyme-linked immunosorbent assays (ELISAs) (see
Fig. S3A in the supplemental material). F2P146/232 did not signifi-
cantly bind heparin in microtiter plate assays (data not shown).
F1P146/232 and F3P146/232 binding to heparin was largely specific, as
the interactions were almost completely (F1P146/232) or mostly
(F3P146/232) inhibited by the addition of a 50 excess unlabeled
heparin. Affinity constants (Kd) of 53 10 nM and 520 80 nM
were calculated for F1P146/232 and F3P146/232, respectively. Pre-
incubation of biotinylated heparin with unlabeled heparin or
fucoidan inhibited binding of F1P146/232 and F3P146/232, while
FIG 3 P146 is processed variably in M. hyopneumoniae laboratory strains and field isolates. (A) Immunoblots of whole-cell lysates of different M. hyopneu-
moniae strains and field isolates. The blots were separately probed with anti-F1P146 (F1P146), anti-F2bP146 (F2bP146), and anti-F3P146 (F3P146) sera in order to
assess the consistency of protein expression and processing. Cleavage fragments equivalent to P50P146, P40P146, and P85P146 are conserved across all isolates in this
study, but some also show distinct bands at higher masses that correspond to fragments that would result from inefficient cleavage. (B) 1-D SDS-polyacrylamide
gel (molecular mass region ~75 to 125 kDa) of an M. hyopneumoniae strain 232 cell lysate was sectioned into 6 slices, and each slice was examined using
LC-MS/MS. (C) Slice 1 (~110 to 125 kDa) was found to contain peptides unique to regions of P146 corresponding to P40P146 and P85P146 fragments and matched
a band found at a similar mass in strain 232 immunoblots. (D) Slices 5 and 6 (~75 to 85 kDa) were found to contain peptides unique to all major fragments of
P146, suggesting that a cleavage event separated the protein into two separate ~80-kDa fragments.
Bogema et al.
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preincubation with porcine mucin or chondroitin sulfate B had
limited or no significant effect (see Fig. S3B in the supplemen-
tal material).
F3P146 binds plasminogen. In M. hyopneumoniae and other
bacterial pathogens, surface proteins possessing a C-terminal
lysine residue have been correlated with the ability to bind the
serine protease precursor plasminogen (25–27, 38). P146 ho-
mologs in strains J, F7.2C, and BQ14 possess a C-terminal lysine
residue (-SSSSAPAAAAAKAAK); however, in strains 232, 7448,
and 168, the terminating residue is an arginine
(-SSSSAPAAAAAAKAAR). To determine whether this sequence
variability influences interactions with plasminogen, we cloned
F3P146 from both strains 232 and J and examined their binding to
plasminogen using dot blotting and surface plasmon resonance
(SPR). In dot blotting experiments, the J and 232 versions (F3P146/J
and F3P146/232) bound biotinylated plasminogen similarly (see
Fig. S4A and S4B in the supplemental material). SPR experiments
indicated that both also bound plasminogen in a dose-dependent
manner with Kd 39 3 nM and association rate (ka) (4.6
0.5) 104 M1 s1 for F3P146/J and Kd 46 6 nM and ka (1.7
 0.5) 105 M1 s1 for F3P146/232 (see Fig. S4C and S4D in the
supplemental material). This suggests that whether the
C-terminal basic residue is arginine or lysine has little effect on
binding affinity; it does modestly affect the kinetics of interaction,
with recognition of arginine being ~4-fold more efficient than
lysine.
To examine this further, we cloned strain J and 232 versions of
F3P146 without their respective C-terminal residues (F3P146/JK
and F3P146/232K); these two proteins have near identical
C-terminal sequences. Both displayed 5-fold-reduced affinity for
plasminogen and as expected showed identical binding affinity
and kinetics; Kd 210 33 nM and ka (1.3 0.2) 104 M1
s1 for F3P146/JK and Kd of 220 33 nM and ka (1.3 0.2)
104 M1 s1 for F3P146/232R (see Fig. S4E and S4F in the supple-
mental material). These data clearly quantify the significance of
having a C-terminal basic residue (a 5-fold contribution to affin-
ity) and whether it is a lysine or an arginine (an effect on binding
kinetics).
P146 fragments bind porcine cilia. A microtiter plate-based
assay used previously to identify cilium-binding proteins showed
that P146 recombinant proteins F1P146/232-F3P146/232 reproducibly
bound cilia (see Fig. S5 in the supplemental material). The recom-
binant protein F4Mhp385, derived from the C terminus of Mhp385
and previously observed to display low cilium-binding properties
(39) did not bind porcine cilia and was included as a negative
binding control in these studies. F2P97, a recombinant protein that
carries the R1 cilium-binding domain of cilium adhesin P97, was
used as a positive control and bound to porcine cilia as expected.
DISCUSSION
Members of the P97/P102 paralog families are secreted to the sur-
face ofM.hyopneumoniaewhere they play key roles in interactions
with host cells, extracellular matrix components, and circulating
host proteins (19, 21–27, 30). There are three overarching features
that define members of these two protein families. The first feature
is the presence of a single putative transmembrane domain at the
N terminus that is not removed by signal peptidase 1 (19, 20, 22).
Second, these molecules undergo endoproteolytic processing
whereby N-terminal cleavage fragments presumably remain teth-
ered to the cell membrane via the N-terminal transmembrane
domain while central and C-terminal endoproteolytic fragments
are released. Despite the absence of transmembrane domains dis-
tant from the N terminus, central and C-terminal cleavage frag-
ments remain attached to the cell surface of M. hyopneumoniae,
presumably by protein-protein interactions that are poorly un-
derstood. Third, P97 and P102 paralogs are multifunctional pro-
teins that bind host cell-associated and circulatory molecules and
present a variety of structural motifs with largely unknown func-
tions (19–22, 24–27).
Here we show that P146, a paralog of P97, contains several
structurally distinctive motifs including a polyserine repeat of un-
known function and a serine/alanine-rich C-terminal motif [SSS-
SAAAAAKAA(K/R)] whose terminal K or R (strain-dependent)
residue plays an important role in binding plasminogen (see
Fig. S4 in the supplemental material). We also identified two pu-
tative coiled-coil regions, one of which carries a KEKE motif, and
FIG4 In silico analysis of P146. (A) Sequence features of P146. The TMHMM algorithm predicts that P146 contains a transmembrane domain (P 0.999). P146
contains three defined repeat regions: P146R1 (PQ), P146R2 (PS), and P146R3 (S). Multiple coiled-coil prediction algorithms identified two putative coiled-coils
flanking the P146R3 repeat region in P85P146. The experimentally determined cleavage site (ATEFQQ) and predicted site (KTYFAE) are also shown. (B) PONDR
VSL1 analysis of P146 232 homolog (Mhp684). The regions above the line at 0.5 denote regions predicted to be structurally disordered within P146. The thick
black bars denote disordered regions spanning 40 or more amino acids. P146 is predicted to contain five regions of significant disorder, two corresponding with
the experimental and predicted cleavage sites. The remaining disordered regions correspond to putative coiled-coil domains, the C-terminal region, and the
P146R3 repeat region.
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a reiterated PQ motif, all of unknown function. Interestingly,
these features are localized to the C-terminal 85 kDa of P146
(P85P146), while sequence similarity with P97 is restricted to the
N-terminal 400 amino acids. Recombinant fragments spanning
different regions of P146 identified at least three cilium-binding
domains located in F1P146/232, F2P146/232, and F3P146/232, while
GAG binding localized to F1P146/232 and F3P146/232. Residual high-
affinity plasminogen binding retained after removal of C-terminal
K/R residues in homologs from strains J and 232 indicate that
additional plasminogen-binding sites are present. These data
show that P146 is a multifunctional protein that binds porcine
respiratory cilia, various GAGs, and plasminogen.
We have previously established that plasminogen is freely
available in the bronchoalveolar regions of the porcine lung (27).
M. hyopneumoniae displays surface receptors that bind plasmino-
gen in a process that facilitates conversion to plasmin by mamma-
lian plasminogen activators (e.g., tPA). Importantly, plasmin ac-
tivity is significantly increased in the BAL fluid of pigs following
infection with M. hyopneumoniae (27). Consequently, M. hyo-
pneumoniae colonizing the ciliated epithelia is likely to sequester
plasminogen on its cell surface and facilitate its conversion to
plasmin. This process is likely to have ramifications for tissue in-
vasion and systemic infection. To date, including P146, we have
characterized four members of the P97 and P102 families as
plasminogen-binding proteins, three of which contain C-terminal
lysine residues (25–27). P146 is particularly interesting due to the
variation of the C-terminal residue; the C-terminal residue was
arginine in strains 232, 7448, and 168 and lysine in strains J, F7.2C,
and BQ14. Lysine and arginine are both positively charged at
physiological pH. We have shown that both strain J and 232 ver-
sions of F3P146 bind plasminogen using dot blotting and SPR.
While the binding of plasminogen by proteins with C-terminal
lysines is well established, binding of plasminogen by proteins
with a C-terminal arginine residue is unusual. However, the Strep-
tococcus pyogenes Prp protein has been shown to bind plasmino-
gen via an internal arginine residue (40), and certain arginyl resi-
dues have been shown to bind human plasminogen kringle 4 (41).
Thrombin-cleaved prourokinase has also been shown to bind hu-
man plasminogen via a C-terminal arginine present at the throm-
bin cleavage site (42).
F3P146/232 and F3P146/J affinity for plasminogen is reduced
5-fold upon removal of the C-terminal Lys/Arg but is not elimi-
nated, indicating the presence of other binding motifs within the
F3P146 sequences. Both F3P146/232 and F3P146/J are rich in internal
lysine residues (66 and 68 lysines, respectively). Additionally, all
known homologs of P146 possess a second lysine, 4 or 5 residues
from the C terminus within a string of 7 or 8 alanine residues
depending upon the strain. This near-C-terminal lysine or other
internal lysines may be responsible for residual plasminogen bind-
ing observed in the F3P146/JK and F3P146/232R mutants. Plasmin-
ogen binding by enolase from group A streptococci has previously
been probed by mutation of C-terminal and internal lysines (43).
Removal or replacement of C-terminal lysines with retention of
internal lysines resulted in a significant reduction in the extent of
binding (43). However, removal of some internal lysines also re-
sulted in a significant reduction in the extent of binding, indicat-
ing that internal lysines also play an import role in plasminogen
binding by enolase (43). Removal of internal lysines by site-
directed mutagenesis and subsequent binding assays may also de-
termine whether these residues have a role in F3P146 adherence to
plasminogen.
LC-MS/MS of proteins resolved by 1- and 2-D gel electropho-
resis identified endoproteolytic cleavage fragments representing
P50P146, P40P146, and P85P146. Two sequences that conform to the
S/T-X-F2X-D/E cleavage motif described recently (22) were
identified in regions spanning tryptic peptides that define these
cleavage fragments. We confirmed the identity of one cleavage site
by LC-MS/MS analysis of the semitryptic peptide 676QQQDAN-
STNSSPTSPSPSPTSPSPASPSSSPSPTSPK712 which defines the N
terminus of the C-terminal cleavage fragment P85P146. The cleav-
age motif 673TEFQQ677 displays a S/T residue in the3 position,
and cleavage occurs at the Phe residue residing at position 1.
Although no D/E is present in the2 position, these features are
in accord with cleavage sites in other members of the P97 and P102
paralogs (22). We were unable to experimentally confirm the pu-
tative cleavage site 351TYFAE355 predicted to generate P50P146 and
P40P146.
Immunoblots of cell lysates of M. hyopneumoniae strains from
different geographic locations probed separately with anti-F1P146
and anti-F3P146 sera showed that cleavage in strain 232 and field
isolates OMZ407, C1735/2, and 00MP1301 is less efficient than in
strain J and field isolates 2-22421 and 95MP1509. We have previ-
ously indicated that P97 (Mhp183) (20) and P159 (Mhp494) (19)
undergo strain-specific processing events. However, the molecu-
lar identities of the strain-specific products were not identified.
For the first time, we show here that strains of M. hyopneumoniae
vary in their ability to efficiently cleave P146. We identified large
endoproteolytic products comprising a C-terminal 120-kDa frag-
ment (P85P146 plus P40P146), derived from an inefficient cleavage
event at the 673TEFQQ677 site and an N-terminal P90P146 fragment
(P50P146 plus P40P146), derived from inefficient processing at the
putative 351TYFAE355 cleavage site (Fig. 5). P120P146 and P90P146
sequences were identified from high-molecular-mass regions of
cell lysates of strain 232 by LC-MS/MS (Fig. 1B to D) and by
probing cell lysates with anti-F1P146 and anti-F3P146 sera (Fig. 3A).
We also identified minor endoproteolytic cleavage fragments with
masses smaller than the dominant cleavage species P50P146,
P40P146, and P85P146 by enriching biotinylated proteins with avi-
din chromatography (Fig. 5). LC-MS/MS of biotinylated proteins
resolved by 2-D gel electrophoresis confirmed that P50P146 (pre-
FIG 5 Summary of P146 cleavage. Cleavage fragments can be split into three
groups as shown. Strain-specific cleavage fragments are prevalent fragments in
selected strains (e.g., strain 232). Major cleavage fragments P50P146, P40P146,
and P85P146 are abundant in all strains. Minor cleavage fragments are present
in small amounts and are detected only by enrichment of surface proteins.
Bogema et al.
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dicted pI of 9.13) is cleaved to generate two fragments ~25 kDa in
size. The C-terminal half of P50P146 is enriched in acidic amino
acids (D or E residues). LC-MS/MS of a protein spot that migrated
with a mass of ~25 kDa and pI of 5.5 confirmed that the protein
represented the C terminus of P50P146. We have not determined
the precise site of cleavage in P50P146. Minor fragments of P50P146
and P40P146 with different molecular masses were detected with
anti-F1P146 and anti-F2bP146 sera, respectively (Fig. 3). This may
indicate variation at the P50P146 C terminus and P40P146 N termi-
nus caused by minor cleavage events (Fig. 5). LC-MS/MS identi-
fied a 50-kDa N-terminal fragment of P85P146 with a pI of ~5.0. It
is interesting that the minor cleavage fragments identified by LC-
MS/MS display predicted pI values that are considerably more
acidic than those of P50P146 (pI  9.13), P40P146 (9.33), and
P85P146 (7.07), and of intact P146 (8.90). These data suggest that
products of these minor cleavage events are not random break-
down products but represent domains enriched in acidic amino
acids embedded within larger preproteins with strongly basic pIs.
Furthermore, as noted for P159 (Mhp494) and P216 (Mhp493),
regions enriched in acidic amino acid residues are a feature of
members of the P97 and P102 paralog families (19, 21) and un-
derscore their modular structure.
In total, we identified nine proteolytic cleavage fragments rep-
resenting different regions of P146. These fragments are sensitive
to digestion by trypsin, and many were recovered by avidin chro-
matography after the surfaces of M. hyopneumoniae cells were
labeled with biotin. These data show that complex endoproteo-
lytic processing events occur either on the surface of M. hyopneu-
moniae or prior to transport across the cell membrane. Processing
is modulated by the efficiency of cleavage at dominant cleavage
sites because different strains present different cleavage fragments
on their cell surface. The mechanism by which M. hyopneumoniae
regulates endoproteolytic cleavage remains unknown. Nonethe-
less, we have provided further evidence that cleavage often occurs
at sites that conform to the S/T-X-F2X-D/E cleavage motif de-
scribed recently (22). P97 is also subject to extensive endoprote-
olysis, but so far the events that precipitate cleavage and the precise
composition of many of the endoproteolytic fragments have not
been experimentally determined (20). Endoproteolytic process-
ing occurs with all members of the P97 and P102 paralog families,
and in at least two cases (P97 and P146), processing is more ex-
tensive than originally envisaged. Endoproteolytic processing sig-
nificantly increases surface protein diversity by altering the pre-
sentation of functional domains on the cell surface and may be a
mechanism used to regulate adhesion to host tissues, potentiate
host cell invasion, and avoid immune clearance.
MATERIALS AND METHODS
Porcine sera and Mycoplasma hyopneumoniae strains and culture.
Convalescent porcine sera were obtained from finisher pigs from a herd
infected with M. hyopneumoniae in an area where M. hyopneumoniae is
endemic (Joadja, Australia). High-health-status serum was obtained from
a high-health-status herd and tested negative for M. hyopneumoniae in-
fection using a commercial ELISA kit. Pretreatment (negative-control)
serum was obtained from a 9-week-old pig that tested negative to M.
hyopneumoniae by quantitative PCR (qPCR) (44). The pig was subse-
quently vaccinated at 9, 12, and 15 weeks with Suvaxyn. Postvaccination
serum was collected 15 weeks after the third vaccination. The pig was
challenged with M. hyopneumoniae strain Hillcrest at week 17 and post-
challenge serum was collected at week 23. The sources and conditions
used to culture and harvestM. hyopneumoniae strains J, 232, and Hillcrest
and field isolates OMZ407, 00MP1301, 2-2241, C1735-2, and 95MP1509
are as previously described (22, 24, 45).
Proteomics and surface localization. The materials and methods
used for 1- and 2-D GE, immunoblotting, trypsin digestion, Zip-Tip
cleanup, reduction, and alkylation have been previously described (20, 24,
46–48) with the following adjustments. For 2-D GE, first-dimension im-
mobilized pH gradient (IPG) strips (ReadyStrip IPG strips, 110 mm long,
pH 3 to 10; Bio-Rad) were used. The strips were rehydrated overnight with
300 g of biotinylated surface protein in 210 l of solubilization buffer
[7 M urea, 2 M thiourea, 1% (wt/vol) 3-(4-heptyl)phenyl-3-
hydroxypropyl)dimethylammoniopropanesulfonate] and overlaid with
paraffin oil. M. hyopneumoniae proteins were reduced prior to 1-D SDS-
PAGE for immunoblotting and reduced and alkylated with iodoacet-
amide prior to 1-D SDS-PAGE for LC-MS/MS. Gel slices prepared from
1-D SDS-PAGE for LC-MS/MS analysis were processed as previously de-
scribed (24). LC-MS/MS analysis of 1- and 2-D GE excisions were done as
previously described (22, 49), as were graded trypsin digestions of intact
M. hyopneumoniae cells (22) and trypsin digestion experiments for mass
spectrometry and biotinylation of the M. hyopneumoniae surface (22).
Cell integrity for trypsin and biotinylation experiments was evaluated by
flow cytometry with a BDTM LSR II (BD Biosciences, NJ) and YO-PRO-1
iodide dead cell dye (Invitrogen, CA) with data analyzed using BD FAC-
SDiva software (BD Biosciences). Bioinformatic analysis of P146 used
online resources: BLASTP (50), ProtParam (51), COILS (36), Paircoil2
(35), TMHMM (52), SignalP (53), and PONDR VSL1 (37).
Expression of recombinant proteins and creation of polyclonal an-
tisera. Cloning of p146 was performed by using three fragments of differ-
ent lengths (Fig. 2A) and based on the M. hyopneumoniae strain 232 ge-
nome sequence (6); fragments were constructed to mimic the P146
cleavage pattern as determined by preliminary mass spectrometry exper-
iments. The fragments were denoted F1P146/232, F2P146/232, and F3P146/232
and ranged from amino acids 53 to 372, 376 to 690, and 691 to 1317,
respectively. F3P146/J and F3P146/JK were generated from M. hyopneu-
moniae strain J genome sequence (7). In-frame TGA codons were substi-
tuted by TGG and C-terminal residues (F3P146/JK and F3P146/232R) were
removed by use of overlap extension PCR or site-directed mutagenesis
using mutagenic primers (see Table S1 in the supplemental material). The
fragments were amplified by PCR from M. hyopneumoniae strain 232
chromosomal DNA using Pfu polymerase (Aglient Technologies, CA)
and cloned into the pET100/GW/D-TOPO vector (Invitrogen) as de-
scribed previously (24). Protein expression was performed using Esche-
richia coli BL21Star (DE3) as previously described (27) with the following
alterations: protein expression was performed using either LB broth, Ter-
rific broth, or 2 Terrific broth depending on the amount of proteolytic
cleavage observed in preliminary experiments. Expression of recombi-
nant proteins was initiated by incubating cells at 18°C for 30 min prior to
the addition of isopropyl--d-thiogalactopyranoside (IPTG), followed by
incubation at 18°C overnight. Recombinant proteins were purified na-
tively by nickel affinity chromatography and dialyzed in phosphate-
buffered saline (PBS) (Fig. 2B); their concentrations were estimated as
described previously (31). Polyclonal antisera (anti-F1P146/232 and anti-
F3P146/232 sera) to recombinant proteins F1P146/232 and F3P146/232 were
prepared by immunization of New Zealand White rabbits as previously
described (54). Polyclonal antiserum anti-F2bP146 was prepared similarly
with a recombinant protein representing residues 586 to 690 of P146. For
some immunoblots, purified anti-F1P146/232 antibodies were used to re-
move cross-reactions and were prepared as described previously (55). All
antisera were tested for activity by immunoblotting with recombinant
protein (Fig. 2C).
Binding assays.Heparin-binding, inhibition, and competitive immu-
noassays were performed in 96-well, flat-bottomed microtiter plates (Lin-
bro/Titertek; ICN Biomedicals Inc., Aurora, OH) as described elsewhere
(31). The binding of F1P146/232-F3P146/232 to porcine cilia was examined
using a microtiter plate adherence assay developed for the identification of
the cilium-binding protein P97 (21). SPR analyses were performed using
The P146 Adhesin of M. hyopneumoniae
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a BIAcore T100 instrument (Biacore AB, Sweden), operated at 20°C. The
preparation of analyte proteins, ligand immobilization, kinetics assays,
porcine plasminogen purification, and biotinylation of plasminogen have
been described previously (25). Plasminogen was immobilized as a ligand
for SPR assays; binding of recombinant P146 proteins was measured with
a concentration range of 0 to 200 nM. A blank immobilized flow cell was
used as a reference cell. F3P146 association kinetics with plasminogen were
analyzed as the sum of two exponentials for a heterogeneous surface as
described previously (24). Plasminogen dot blots were performed (24)
with 5g ml1 biotinylated porcine plasminogen as described previously.
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